Cholinergic Receptor, Nicotinic Beta 1 (CHRNB1) Peptide
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Cholinergic Receptor, Nicotinic Beta 1 (CHRNB1) Peptide is a synthetic peptide.
Documents del producto
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Cholinergic Receptor, Nicotinic Beta 1 (CHRNB1) |
| Host | Synthetic |
| Recommended Dilution | BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Observed MW | Sequence Fragment: Internal region: C-QEQEDHDALKED |
| Size 1 | 100 µg |
| Form | Lyophilized Reconstitute in deionized water. |
| Tested Applications | P-ELISA |
| Buffer | Prior to lyophilization: Deionized water. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 1140 |
| NCBI Accession | NP_000738.2 |
| Background | Protein CHRNB1 |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products
CHRNB1 antibody
After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
Ver Producto
Cholinergic Receptor, Nicotinic Beta 1 (CHRNB1) Antibody
CHRNB1 Antibody is a Rabbit Polyclonal antibody against CHRNB1. The muscle acetylcholine receptor is composed of five subunits: two alpha subunits and one beta, one gamma, and one delta subunit. This gene encodes the beta subunit of the acetylcholine receptor. The acetylcholine receptor changes conformation upon acetylcholine binding leading to the opening of an ion-conducting channel across the plasma membrane. Mutations in this gene are associated with slow-channel congenital myasthenic syndrome.
Ver Producto
Cholinergic Receptor, Nicotinic Beta 1 (CHRNB1) Antibody
Rabbit Polyclonal against the CHRNB1 protein.
Ver Producto